IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection

Nature Communications

Volumn 6, Issue , 2015, Pages

  Dutta, Avijit ^a   Huang, Ching Tai ^a   Chen, Tse Ching ^a   Lin, Chun Yen ^a   Chiu, Cheng Hsun ^a   Lin, Yung Chang ^a   Chang, Chia Shiang ^a   He, Yueh Chia ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS SIALIDASE; SIALIDASE; TUMOR NECROSIS FACTOR;

ABUNDANCE; ENZYME ACTIVITY; GERM CELL; IMMUNE RESPONSE; INFECTIVITY; INFLUENZA; PHENOTYPE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME RELEASE; IMMUNOREACTIVITY; IN VIVO STUDY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; RECEPTOR UPREGULATION; TH1 CELL; VIRAL CLEARANCE; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOLOGY; ORTHOMYXOVIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923873061     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7374     Document Type: Article

References (48)

1. Schmolke, M. & García-Sastre, A. Evasion of innate and adaptive immune responses by influenza A virus. Cell. Microbiol. 12, 873-880 (2010).
2. van de Sandt, C. E., Kreijtz, J. H. & Rimmelzwaan, G. F. Evasion of influenza A viruses from innate and adaptive immune responses. Viruses 4, 1438-1476 (2012).
3. Simmons, C. & Farrar, J. Insights into inflammation and influenza. N. Engl. J. Med. 359, 1621-1623 (2008).
4. Cheung, C. Y. et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837 (2002).
5. de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207 (2006).
6. Peiris, J. S. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619 (2004).
7. Shen, H. H. et al. Immunologic changes during pandemic (H1N1) 2009, China. Emerg. Infect. Dis. 17, 1053-10555 (2011).
8. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319-323 (2007).
9. Shtyrya, Y. A., Mochalova, L. V. & Bovin, N. V. Influenza virus neuraminidase: structure and function. Acta Naturae 1, 26-32 (2009).
10. Carlson, C. M. et al. Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog. 6, e1001136 (2010).
11. Koli, K., Myllarniemi, M., Keski-Oja, J. & Kinnula, V. L. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid. Redox Signal 10, 333-342 (2008).
12. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. & Flavell, R. A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99-146 (2006).
13. Letterio, J. J. & Roberts, A. B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137-161 (1998).
14. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
15. Gordon, K. J. & Blobe, G. C. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim. Biophys. Acta 1782, 197-228 (2008).
16. Fitzpatrick, D. R. & Bielefeldt-Ohmann, H. Transforming growth factor beta in infectious disease: always there for the host and the pathogen. Trends Microbiol. 7, 232-236 (1999).
17. Reed, S. G. TGF-beta in infections and infectious diseases. Microbes Infect. 1, 1313-1325 (1999).
18. Omer, F. M. & Riley, E. M. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188, 39-48 (1998).
19. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15, 277-284 (2009).
20. + T cells with attenuated cytokine storm and preserved memory in influenza. J. Immunol. 190, 4205-4214 (2013).
21. McKinstry, K. K. et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 182, 7353-7363 (2009).
22. Sun, K., Torres, L. & Metzger, D. W. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J. Virol. 84, 5007-5014 (2010).
23. Lucas, S. J., Barry, D. W. & Kind, P. Antibody production and protection against influenza virus in immunodeficient mice. Infect. Immun. 20, 115-119 (1978).
24. Sarawar, S. R., Sangster, M., Coffman, R. L. & Doherty, P. C. Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J. Immunol. 153, 1246-1253 (1994).
25. + T cells promote the clearance of influenza virus from major histo- compatibility complex class II2/2 respiratory epithelium. J. Virol. 70, 1288-1291 (1996).
26. Román, E. et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196, 957-968 (2002).
27. Schultz-Cherry, S. & Hinshaw, V. S. Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70, 8624-8629 (1996).
28. Huang, C. T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503-513 (2004).
29. Miller, J. F., Morahan, G., Allison, J. & Hoffmann, M. A transgenic approach to the study of peripheral T-cell tolerance. Immunol. Rev. 122, 103-116 (1991).
30. Ullman, K. S., Northrop, J. P., Verweij, C. L. & Crabtree, G. R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8, 421-452 (1990).
31. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19, 683-765 (2001).
32. Kuhn, R., Löhler, J., Rennick, D., Rajewsky, K. & Müller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
33. Milon, G. Listeria monocytogenes in laboratory mice: a model of short-term infectious and pathogenic processes controllable by regulated protective immune responses. Immunol. Rev. 158, 37-46 (1997).
34. Weber-Nordt, R. M., Meraz, M. A. & Schreiber, R. D. Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J. Immunol. 153, 3734-3744 (1994).
35. Zigmond, E. et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720-733 (2014).
36. Lee, C. G. et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation and airway remodeling via IL-13 dependent and independent pathways. J. Biol. Chem. 277, 35466-35474 (2002).
37. Lauw, F. N. et al. Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol. 165, 2783-2789 (2000).
38. Go, N. F. et al. Interleukin 10 (IL-10), a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172, 1625-1631 (1990).
39. MacNeil, I., Suda, T., Moore, K. W., Mosmann, T. R. & Zlotnik, A. IL-10: a novel cytokine growth cofactor for mature and immature T cells. J. Immunol. 145, 4167-4173 (1990).
40. Chen, W.-F. & Zlotnik, A. Interleukin 10: A novel cytotoxic T cell differentiation factor. J. Immunol. 147, 528-534 (1991).
41. + T cells mediate tumor rejection. J. Immunol. 168, 1-4 (2002).
42. Thompson-Snipes, L. et al. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510 (1991).
43. Ishida, H. et al. Continuous administration of anti-IL-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179, 305-310 (1994).
44. Ding, Y. et al. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol. 167, 6884-6892 (2001).
45. Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514-518 (2011).
46. Wang, X. et al. A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell. Mol. Immunol. 8, 462-468 (2011).
47. + regulatory T cells is essential for preventing experimental graft-versus-host disease. J. Immunol. 189, 2890-2896 (2012).
48. Triebel, F. et al. LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 171, 1393-1405 (1990).